Extendicare Inc. (EXETF)
USD 7.0
(-0.71%)
USD 7.0
(-0.71%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 584.81 Million CAD | -14.11% |
| 2022 | 680.87 Million CAD | -14.72% |
| 2021 | 798.4 Million CAD | -4.38% |
| 2020 | 834.93 Million CAD | 7.96% |
| 2019 | 773.38 Million CAD | 0.4% |
| 2018 | 770.33 Million CAD | -4.35% |
| 2017 | 805.32 Million CAD | -1.05% |
| 2016 | 813.85 Million CAD | -4.79% |
| 2015 | 854.81 Million CAD | -55.43% |
| 2014 | 1.91 Billion CAD | 5.88% |
| 2013 | 1.81 Billion CAD | 3.31% |
| 2012 | 1.75 Billion CAD | -1.63% |
| 2011 | 1.78 Billion CAD | 6.14% |
| 2010 | 1.67 Billion CAD | -1.73% |
| 2009 | 1.7 Billion CAD | -6.89% |
| 2008 | 1.83 Billion CAD | 25.4% |
| 2007 | 1.46 Billion CAD | 9.33% |
| 2006 | 1.33 Billion CAD | 11.5% |
| 2005 | 1.2 Billion CAD | 23.88% |
| 2004 | 969.34 Million CAD | -21.64% |
| 2003 | 1.23 Billion CAD | -14.8% |
| 2002 | 1.45 Billion CAD | 4.48% |
| 2001 | 1.38 Billion CAD | 2.65% |
| 2000 | 1.35 Billion CAD | -3.08% |
| 1999 | 1.39 Billion CAD | -10.65% |
| 1998 | 1.56 Billion CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 599.64 Million CAD | -1.82% |
| 2024 Q1 | 610.74 Million CAD | 4.43% |
| 2023 Q2 | 673.49 Million CAD | 4.51% |
| 2023 Q4 | 584.81 Million CAD | -1.28% |
| 2023 Q1 | 644.42 Million CAD | -5.35% |
| 2023 FY | 584.81 Million CAD | -14.11% |
| 2023 Q3 | 592.36 Million CAD | -12.05% |
| 2022 Q4 | 680.87 Million CAD | 4.87% |
| 2022 FY | 680.87 Million CAD | -14.72% |
| 2022 Q1 | 801.36 Million CAD | 0.37% |
| 2022 Q3 | 649.28 Million CAD | -0.67% |
| 2022 Q2 | 653.65 Million CAD | -18.43% |
| 2021 Q2 | 788.4 Million CAD | -2.1% |
| 2021 Q3 | 792.93 Million CAD | 0.57% |
| 2021 Q4 | 798.4 Million CAD | 0.69% |
| 2021 Q1 | 805.35 Million CAD | -3.54% |
| 2021 FY | 798.4 Million CAD | -4.38% |
| 2020 Q4 | 834.93 Million CAD | 3.03% |
| 2020 FY | 834.93 Million CAD | 7.96% |
| 2020 Q3 | 810.4 Million CAD | -0.32% |
| 2020 Q2 | 813 Million CAD | 6.72% |
| 2020 Q1 | 761.81 Million CAD | -1.5% |
| 2019 Q1 | 770.73 Million CAD | 0.05% |
| 2019 FY | 773.38 Million CAD | 0.4% |
| 2019 Q2 | 782.54 Million CAD | 1.53% |
| 2019 Q3 | 785.8 Million CAD | 0.42% |
| 2019 Q4 | 773.38 Million CAD | -1.58% |
| 2018 Q1 | 802.32 Million CAD | -0.37% |
| 2018 Q3 | 785.64 Million CAD | 0.16% |
| 2018 Q4 | 770.33 Million CAD | -1.95% |
| 2018 FY | 770.33 Million CAD | -4.35% |
| 2018 Q2 | 784.37 Million CAD | -2.24% |
| 2017 Q2 | 819.21 Million CAD | 1.7% |
| 2017 Q4 | 805.32 Million CAD | -0.9% |
| 2017 FY | 805.32 Million CAD | -1.05% |
| 2017 Q1 | 805.53 Million CAD | -1.02% |
| 2017 Q3 | 812.61 Million CAD | -0.81% |
| 2016 Q2 | 783.7 Million CAD | -2.95% |
| 2016 FY | 813.85 Million CAD | -4.79% |
| 2016 Q4 | 813.85 Million CAD | -1.13% |
| 2016 Q3 | 823.12 Million CAD | 5.03% |
| 2016 Q1 | 807.52 Million CAD | -5.53% |
| 2015 Q1 | 2.01 Billion CAD | 5.03% |
| 2015 Q4 | 854.81 Million CAD | -3.19% |
| 2015 Q3 | 882.95 Million CAD | -59.47% |
| 2015 Q2 | 2.17 Billion CAD | 8.14% |
| 2015 FY | 854.81 Million CAD | -55.43% |
| 2014 Q1 | 1.84 Billion CAD | 1.66% |
| 2014 FY | 1.91 Billion CAD | 5.88% |
| 2014 Q3 | 1.89 Billion CAD | 3.73% |
| 2014 Q4 | 1.91 Billion CAD | 1.35% |
| 2014 Q2 | 1.82 Billion CAD | -0.92% |
| 2013 Q1 | 1.77 Billion CAD | 1.37% |
| 2013 Q3 | 1.76 Billion CAD | -1.38% |
| 2013 Q4 | 1.81 Billion CAD | 2.72% |
| 2013 FY | 1.81 Billion CAD | 3.31% |
| 2013 Q2 | 1.78 Billion CAD | 0.6% |
| 2012 Q1 | 1.73 Billion CAD | -2.59% |
| 2012 Q3 | 1.81 Billion CAD | 4.36% |
| 2012 Q4 | 1.75 Billion CAD | -3.56% |
| 2012 FY | 1.75 Billion CAD | -1.63% |
| 2012 Q2 | 1.74 Billion CAD | 0.34% |
| 2011 Q3 | 1.9 Billion CAD | 1.41% |
| 2011 Q4 | 1.78 Billion CAD | -6.22% |
| 2011 FY | 1.78 Billion CAD | 6.14% |
| 2011 Q1 | 1.86 Billion CAD | 10.78% |
| 2011 Q2 | 1.87 Billion CAD | 0.74% |
| 2010 Q4 | 1.67 Billion CAD | -0.06% |
| 2010 Q3 | 1.68 Billion CAD | -1.85% |
| 2010 Q1 | 1.67 Billion CAD | -1.76% |
| 2010 Q2 | 1.71 Billion CAD | 1.97% |
| 2010 FY | 1.67 Billion CAD | -1.73% |
| 2009 Q3 | 1.69 Billion CAD | -3.69% |
| 2009 Q1 | 1.87 Billion CAD | 2.16% |
| 2009 Q2 | 1.75 Billion CAD | -6.26% |
| 2009 Q4 | 1.7 Billion CAD | 0.94% |
| 2009 FY | 1.7 Billion CAD | -6.89% |
| 2008 Q4 | 1.83 Billion CAD | 11.76% |
| 2008 Q1 | 1.53 Billion CAD | 4.71% |
| 2008 Q2 | 1.57 Billion CAD | 2.99% |
| 2008 Q3 | 1.64 Billion CAD | 4.04% |
| 2008 FY | 1.83 Billion CAD | 25.4% |
| 2007 FY | 1.46 Billion CAD | 9.33% |
| 2007 Q4 | 1.46 Billion CAD | 13.16% |
| 2007 Q3 | 1.29 Billion CAD | -3.44% |
| 2007 Q2 | 1.33 Billion CAD | 0.27% |
| 2007 Q1 | 1.33 Billion CAD | -0.22% |
| 2006 Q2 | 1.21 Billion CAD | -2.2% |
| 2006 Q3 | 1.29 Billion CAD | 6.45% |
| 2006 FY | 1.33 Billion CAD | 11.5% |
| 2006 Q1 | 1.23 Billion CAD | 3.21% |
| 2006 Q4 | 1.33 Billion CAD | 3.77% |
| 2005 Q3 | 1.19 Billion CAD | -5.83% |
| 2005 FY | 1.2 Billion CAD | 23.88% |
| 2005 Q1 | 1.27 Billion CAD | 31.49% |
| 2005 Q2 | 1.27 Billion CAD | -0.06% |
| 2005 Q4 | 1.2 Billion CAD | 0.1% |
| 2004 FY | 969.34 Million CAD | -21.64% |
| 2004 Q4 | 969.34 Million CAD | -6.65% |
| 2004 Q3 | 1.03 Billion CAD | -7.56% |
| 2004 Q2 | 1.12 Billion CAD | -7.03% |
| 2004 Q1 | 1.2 Billion CAD | -2.33% |
| 2003 Q4 | 1.23 Billion CAD | -4.18% |
| 2003 FY | 1.23 Billion CAD | -14.8% |
| 2003 Q1 | 1.35 Billion CAD | 0.0% |
| 2003 Q2 | 1.28 Billion CAD | -5.01% |
| 2003 Q3 | 1.29 Billion CAD | 0.43% |
| 2002 FY | 1.45 Billion CAD | 4.48% |
| 2001 FY | 1.38 Billion CAD | 2.65% |
| 2000 FY | 1.35 Billion CAD | -3.08% |
| 1999 FY | 1.39 Billion CAD | -10.65% |
| 1998 FY | 1.56 Billion CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| The Amacore Group, Inc. | 24.7 Million USD | -2266.732% |
| Arem Pacific Corporation | 304.9 Thousand USD | -191702.311% |
| Assisted 4 Living, Inc. | 184.16 Thousand USD | -317443.86% |
| BioCorRx Inc. | 10.34 Million USD | -5555.041% |
| Bionik Laboratories Corp. | 5 Million USD | -11589.872% |
| Banyan Corp. | 4.51 Million USD | -12842.781% |
| Clearday, Inc. | 65.13 Million USD | -797.885% |
| Dental Patient Care America, Inc. | 1.8 Million USD | -32351.622% |
| Quantum Medical Transport, Inc. | 1504.02 USD | -38883093.043% |
| Empower Clinics Inc. | 9.18 Million USD | -6266.509% |
| First Choice Healthcare Solutions, Inc. | 31.65 Million USD | -1747.552% |
| Selectis Health, Inc. | 43.63 Million USD | -1240.226% |
| Ethema Health Corporation | 17.71 Million USD | -3200.389% |
| HealthLynked Corp. | 3.47 Million USD | -16727.108% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.47 Million USD | -3940.215% |
| JRSIS Health Care Corporation | 2.3 Million USD | -25269.462% |
| Comjoyful International Company | 6.32 Million USD | -9144.423% |
| Medical Facilities Corporation | 235.37 Million USD | -148.463% |
| MedSmart Group Inc. | 927.53 Thousand USD | -62950.292% |
| North America Frac Sand, Inc. | 936.85 Thousand USD | -62323.12% |
| Nova Leap Health Corp. | 2.69 Million USD | -21568.045% |
| Nexteligent Holdings, Inc. | 2.88 Million USD | -20190.91% |
| PAO Group, Inc. | 1.04 Million USD | -55779.25% |
| Primemd Inc. | 7.98 Million USD | -7220.484% |
| Raffles Medical Group Ltd | 367.04 Million USD | -59.328% |
| Ryman Healthcare Limited | 5.17 Billion USD | 88.71% |
| Stem Cell Authority, Ltd. | 80.52 Thousand USD | -726147.749% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 3.91 Million USD | -14834.577% |
| Mycotopia Therapies, Inc. | 4.24 Million USD | -13667.635% |
| U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -86410.503% |
| Veltex Corporation | 2.87 Million USD | -20225.43% |
| World Financial Holding Group | 132.5 Thousand USD | -441250.138% |
| Xcelerate Inc. | 2.07 Million USD | -28075.923% |